We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner purposes approximately under 70 brands. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. Wanbury Limited also exports its products. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.
TODAY'S HIGH
67
TODAY'S LOW
65.2
52 WEEK HIGH
112
52 WEEK LOW
55.05
% of Shares Held by
All Insider
60.03%
% of Shares Held by
Institutions
3.87%
% of Float Held by
Institutions
9.68%
Number of Institutions
Holding Shares
1
MARKET CAP
216.73 Cr.
ETERPRISE VALUE
268.17 Cr.
NO. OF SHARES
3.26 Cr.
BOOK VALUE
-7.269
DIV. YIELD
1%
DEBT
73.60 Cr.
GROSS PROFIT
210.89 Cr.
CASH
25.31 Cr.
REVENUE
511.18 Cr.
REVENUE/SHARE
158.675
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Investments | 0 | 0 | 0 | 0 |
| Change To Liabilities | 64.97 Cr. | 14.31 Cr. | 8.55 Cr. | 29.72 Cr. |
| Total cashflows from Investing Activities | 58.65 Lakhs | 8.04 Cr. | 63.66 Cr. | -3.07 Cr. |
| Net Borrowings | -64.98 Cr. | -10.64 Cr. | -97.07 Cr. | -15.40 Cr. |
| Total Cash from Financing Activities | -25.62 Cr. | -17.38 Cr. | -107.87 Cr. | -26.78 Cr. |
| Other Liabilities | -11.71 Cr. | -18.61 Cr. | 10.43 Cr. | 2.17 Cr. |
| Total Assets | 49.66 Cr. | 2 Lakhs | 2.50 Lakhs | 2.50 Lakhs |
| Net Income | 81.47 Cr. | -12.60 Cr. | 64.46 Cr. | -24.84 Cr. |
| Change in Cash | 12.52 Cr. | 7.34 Cr. | -7.90 Lakhs | -12.75 Lakhs |
| Effect of Exchange Rate | 0 | 0 | 0 | 0 |
| Total Cash from Operating Activities | 37.56 Cr. | 16.68 Cr. | 44.13 Cr. | 29.73 Cr. |
| Depreciation | 11.44 Cr. | 9.54 Cr. | 9.46 Cr. | 9.75 Cr. |
| Other Cashflows from Investing Activities | -55.39 Lakhs | 12.44 Cr. | -11.35 Cr. | 1.62 Cr. |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Change to Inventory | -24.87 Cr. | -12.59 Cr. | 7.07 Cr. | -6.26 Cr. |
| Change to Account Receivables | -28.09 Cr. | 13.88 Cr. | -5.16 Cr. | -13.76 Cr. |
| Other Cashflows from Financing Activities | -10.29 Cr. | -6.76 Cr. | -10.82 Cr. | -11.37 Cr. |
| Change to Net Income | -55.64 Cr. | 22.53 Cr. | -50.91 Cr. | 32.73 Cr. |
| Capital Expenditures | -9.65 Cr. | -4.42 Cr. | -7.83 Cr. | -4.71 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Research Development | None | None | None | None |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | 81.12 Cr. | -12.40 Cr. | 64.67 Cr. | -24.98 Cr. |
| Minority Interest | None | None | None | None |
| Net Income | 25.37 Cr. | 11.20 Cr. | 13.87 Cr. | 6.65 Cr. |
| Selling General Administrative | 74.80 Cr. | 69.23 Cr. | 79.52 Cr. | 93.71 Cr. |
| Gross Profit | 210.89 Cr. | 170.27 Cr. | 181.45 Cr. | 190.04 Cr. |
| Ebit | 25.37 Cr. | 11.20 Cr. | 13.87 Cr. | 6.65 Cr. |
| Operating Income | 25.37 Cr. | 11.20 Cr. | 13.87 Cr. | 6.65 Cr. |
| Other Operating Expenses | 99.26 Cr. | 80.07 Cr. | 78.36 Cr. | 79.71 Cr. |
| Interest Expense | -20.61 Cr. | -23.07 Cr. | -32.87 Cr. | -39.88 Cr. |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | -34.62 Lakhs | 20 Lakhs | 20.87 Lakhs | -13.66 Lakhs |
| Total Revenue | 511.18 Cr. | 392.51 Cr. | 367.45 Cr. | 391.37 Cr. |
| Total Operating Expenses | 485.81 Cr. | 381.30 Cr. | 353.57 Cr. | 384.72 Cr. |
| Cost of Revenue | 300.28 Cr. | 222.24 Cr. | 185.99 Cr. | 201.32 Cr. |
| Total Other Income Expense Net | 55.75 Cr. | -23.61 Cr. | 50.79 Cr. | -31.63 Cr. |
| Discontinued Operations | None | None | None | None |
| Net Income from Continuous Ops. | 81.47 Cr. | -12.60 Cr. | 64.46 Cr. | -24.84 Cr. |
| Net Income Applicable to Common Shares | 81.47 Cr. | -12.60 Cr. | 64.46 Cr. | -24.84 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Intangible Assets | 10.13 Lakhs | 22.75 Lakhs | 41.29 Lakhs | 57.65 Lakhs |
| Capital Surplus | 0 | 60.07 Cr. | 59.99 Cr. | 59.50 Cr. |
| Total Liabilities | 375.96 Cr. | 418.75 Cr. | 395.48 Cr. | 468.66 Cr. |
| Stock Holder Equity | -23.41 Cr. | -156.24 Cr. | -143.45 Cr. | -209.27 Cr. |
| Minority Interest | 0 | 0 | 0 | 0 |
| Other Liabilities | 95.71 Cr. | 60.49 Cr. | 57.85 Cr. | 62.82 Cr. |
| Total Assets | 352.54 Cr. | 289.17 Cr. | 278.69 Cr. | 286.04 Cr. |
| Common Stock | 32.66 Cr. | 25.01 Cr. | 24.99 Cr. | 23.72 Cr. |
| Retained Earnings | 0 | -252.76 Cr. | -239.71 Cr. | -303.72 Cr. |
| Other Liabilities | 12.06 Cr. | 13.75 Cr. | 11.56 Cr. | 10.69 Cr. |
| Good Will | 0 | 0 | 0 | 0 |
| Treasury Stock | -56.08 Cr. | 11.43 Cr. | 11.27 Cr. | 11.22 Cr. |
| Other Assets | 6.11 Cr. | 9.49 Cr. | 7.26 Cr. | 6.54 Cr. |
| Cash | 25.31 Cr. | 10 Cr. | 2.66 Cr. | 2.74 Cr. |
| Current Liabilities | 359.77 Cr. | 328.69 Cr. | 284.38 Cr. | 334.93 Cr. |
| Long Term Asset Charges | 5.63 Cr. | 5.63 Cr. | 3.36 Cr. | 3.36 Cr. |
| Short Long Term Debt | 67.02 Cr. | 83.60 Cr. | 57.18 Cr. | 52.78 Cr. |
| Other Stockholder Equity | -56.08 Cr. | 11.43 Cr. | 11.27 Cr. | 11.22 Cr. |
| Property Plant Equipment | 169.35 Cr. | 178.17 Cr. | 177.37 Cr. | 180.75 Cr. |
| Total Cur. Assets | 173.20 Cr. | 101.26 Cr. | 93.63 Cr. | 98.15 Cr. |
| Long Term Investments | 3.77 Cr. | 1.32 Lakhs | 68 k | 1.98 Lakhs |
| Net Tangible Assets | -23.52 Cr. | -156.47 Cr. | -143.86 Cr. | -209.85 Cr. |
| Short Term Investments | 0 | 13.01 Lakhs | 12.03 Cr. | 0 |
| Net Receivables | 63.94 Cr. | 56.68 Cr. | 55.34 Cr. | 65.86 Cr. |
| Long Term Debt | 0 | 71.99 Cr. | 99.54 Cr. | 123.03 Cr. |
| Inventory | 49.72 Cr. | 24.85 Cr. | 12.25 Cr. | 19.33 Cr. |
| Accounts Payable | 191.61 Cr. | 133.76 Cr. | 121.86 Cr. | 112.23 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account